As we head into 2026, the flagship smartphone landscape is shaping up to be more fiercely competitive than ever. This year, manufacturers are pushing boundaries with ultra-high-definition cameras, ...

Takeda has partnered with China's Innovent Biologics for a pair of late-stage cancer therapies, in a deal that includes an upfront payment of $1.2 billion and could be worth up to $11.4 billion. The ...